Junior Researchers

Current Issue

Vol. 3 No. 2 (2025)
Published May 19, 2025
Conference on Innovations in Parkinson’s Disease and Movement Disorders

On 2-3 May, 2025 at Ivane Beritashvili Center of Experimental Biomedicine Georgian Neuroscience Association (GNA) under support of International Brain Research Association (IBRO) organized an international Conference on Innovations in Parkinson’s Disease and Movement Disorders. The aim of this international medical conference was to bring together experts in neurology and neuroscience to share insights on the diagnosis and management of Parkinson’s disease and other motor disorders related to autonomic nervous system dysfunction. This event welcomed both established and emerging neurologists from Georgia and other countries, including Tunisia, Ethiopia, fostering discussions on controversial topics and exchanging practical knowledge with Georgian and international medical students interested in neuroscience. Conference hosted online and offline participants from Greece, Romania, Armenia, Ukraine, Iran, Tunisia, India, Poland. The two-day conference featured interactive sessions, oral and poster presentations, workshops, and networking opportunities over lunch and coffee breaks.

Articles

Syed Iftiqar Ahmed, Jay Gagwani, Amy Elizabeth Mathew, Syed Mohammed Aiyman, Ahmed Usama Rizvi
1-12
Fever to Tremor: Exploring the link between Encephalitis and Parkinsonian Syndrome
pdf
Varun Dwivedi, Pragati Pande
13-18
Personalized DAT Selection in Advanced Parkinson’s Disease: A Milestone-Guided, Phenotype-Aligned Framework
pdf
Saif Muhammad Khan, Areeba Hasan
19-22
Peripheral Detection of α-Synuclein in Parkinson’s Disease: A Systematic Review of Minimally and Noninvasive Biomarkers
pdf
Rotaru Constantin-Călin, Rebenciuc Tudor-Ștefan, Trandafir Cristiana Maria, Savin Ilie-Andreas
23-24
The Impact of Aerobic Exercise on Motor and Cognitive Outcomes in Individuals with Parkinson’s Disease
pdf
Hetvi Patel
25-26
The Skin Speaks First: Uncovering the Early Diagnostic Potential of Parkinson’s Disease Through Dermatological Manifestations
pdf
Esther Amarachi Ojukwu, Victoria Ezinne Ojukwu, Jean-Mark Davis
27-41
Evaluating Probiotic therapy as a Gut-Brain Microbiota and Neuroinflammation Modulator in Parkinson's disease: A Systematic Review
pdf
Anudi Peiris, Nethmi Weerasinghe, Dr. Nino Tchikadze, Marina Janelidze, Irine Khatiashvili
42-46
Phenylketonuria Associated Early Onset Parkinsonism: A Case of Rapid Progression Following Dietary Nonadherence
pdf
Modi Dhruv, Aalia Quadri
47-48
Evaluating the Therapeutic Potential of Cannabis in Parkinson's Disease Management
pdf
Samiksha Ravindra Balaguragi, Anushka Sen, Pearl Marie Mathew, Vaishnavi Suresh
49-53
Nilotinib In Parkinson’s Disease: A Therapeutic Pathway Yet to Be Fulfilled
pdf
Isha Ullal, Sana Sajed Pathan
54-59
Mitochondrial Targeting by Resveratrol in Parkinson’s Disease: A Multifaceted Approach Against Oxidative Damage and Neurodegeneration
pdf
Syed Khaja Ayaanuddin, Faizan Mansuri, Maroof Shaikh, Arian Hizomi, Syeda Fatima zehra
60-73
Neurons, Nerves, and the Microbial Nexus: Reimagining Parkinson’s Disease from the Inside Out
pdf
Matthew-Zane Lloyd Broderick
74-84
Animal Models and Their Utility in Parkinson’s Disease Research: A Review
pdf
Cristiana-Maria Trandafir, Simona-Ștefania Juncu
85-86
A Turning Point in Parkinson’s Disease Treatment: Targeting Progression, Not Just Symptoms
pdf
Cristiana-Maria Trandafir, Călin-Constantin Rotaru, Tudor-Ștefan Rebenciuc, Simona-Ștefania Juncu
87-88
Do All Roads Lead to Rome? - Rethinking Parkinson’s Disease Through the Gut-Brain Axis
pdf
Apurva Sudesh Abitkar
89-98
The Future Is Cyborg: Neuroprosthetic Interfaces to Aid Parkinsonian Motor Dysfunction
pdf
Maryam Jafarianalvar
99-109
Selecting Cognitive Screening Tools for Mild Cognitive Impairment: A Guide Based on Literacy, Time, and Setting
pdf
Mariami Varazashvili
110-113
Mitochondrial Dysfunction: A Precision Therapeutic Target in Parkinson’s Disease
pdf
Jugal Kishore B, Giorgi Kipiani, Nini Nadiradze, Nino Pochkhidze, Mzia Zhvania
114-122
Telomere Shortening and Cellular Senescence in Parkinson’s Disease: A Converging Axis of Aging and Neurodegeneration
pdf
Teimurazi Tchikhoria, Otari Chankseliani, Marina Chanturia
123-127
Early-Onset Corticobasal Degeneration: A Case of Rapidly Progressive Dementia with primary Progressive Aphasia and Severe Behavioral Disturbances
pdf
Alin-Ștefan Vizitiu, Vitalie Văcăraș
128-134
When Lyme Neuroborreliosis Mimics Multiple Sclerosis. Challenges and Advances in Differential Diagnosis
pdf
Ayesha Huma Inam, Givi Barbakadze
135-136
Device-Assisted and Lesioning Procedures in the Management of Parkinson’s Disease: A Therapeutic Evolution
pdf
Dawson Rebello, Abbas Hussain, Abbas Hatim, Amaan Vajrala, Dr. Irina Khatiashvili
137-139
Procedure vs. Practice - Exploring the Impacts of Procedural Deviations in Deep Brain Stimulation for Parkinsonism
pdf
Angeline Abraham, Akshit Valsaraj Chemmancheri, Akshaya Srinivasan, Anugrah Pradeep, Afnan Ahmed Azad, Nisrine Liyakat Nimachwala
140-150
The Magnetic Cure? Nanotechnology’s Role in Parkinson’s Future : A Systematic Review
pdf
Aryaa Harshal Jadhav, Insha Samsulhuda Khan
151-158
Shifting from Neurotoxic to Neuroprotective States: Exploring Therapeutic Approaches to Modulate Microglial Polarization M1/M2 in Parkinson’s Disease
pdf
Deimile Marija Gritenaitė, Neethu Sara Jiji, Astha Sharma, Chrisla Godwin, Angela John, Fayha Jinan Faizal, Deimile Marija Gritenaite
159-175
Beyond Diabetes Mellitus and weight loss: the potential effect of GLP-1 agonist drugs in the treatment of Parkinson’s Disease
pdf
Monika Sharma, Prateek Singh, Pankaj Yadav, Navratan Suthar
176-192
Prevalence of Drug-Induced Movement Disorders in Mental Disorders using AI- Powered Data Extraction: A Meta-analysis and Systematic Review
pdf
Monika Sharma, Navratan Suthar, Pankaj Yadav
193-211
Extrapyramidal Symptoms in Psychiatric Disorders: Current Insights, Risk Factors, and Future Directions: A Narrative Review
pdf
Snegaa Sathasivan, Jessica Annamalai, Shaheen Kauser Sadhik Bathcha, Joshua Annamalai
212-226
Nanotechnology Based Drug Delivery and Marine Diet Derived Compounds in Alpha-Synuclein-Linked Parkinson’s Disease
pdf
Asadullah Hussain Mohammed Athaullah Hussain, Rahul Rabindar, Hafsa Fathima Athaullahhussain
227-236
The Role of Gut Microbiome Dysbiosis in Alpha-Synuclein Aggregation and Parkinson’s Disease Progression: Can Microbial Markers Predict Clinical Outcomes?
pdf
Ruchi Bikaji Gawde, Samiksha Pravin Poojary
237-248
A New Direction in Parkinson’s Treatment: Slowing Disease Progression by Targeting Alpha-synuclein
pdf
View All Issues